Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:diseases:kidney_stones [07.08.2011] – [Role of elevated 1,25-D] paulalberthome:diseases:kidney_stones [01.03.2012] – external edit 127.0.0.1
Line 5: Line 5:
  
  
-Kidney stones, also called renal calculi, are crystal aggregations of dissolved minerals in urine. Kidney stones typically form inside the kidneys or bladder and can primarily consist of a variety of substances including calcium oxalate, uric acid, and struvite (magnesium, ammonium and phosphate). There are two factors that seem to play a role in kidney stone formation: elevated levels of 1,25-D and the presence of bacteria.  +Kidney stones, also called renal calculi, are crystal aggregations of dissolved minerals in urine. Kidney stones typically form inside the kidneys or bladder and can primarily consist of a variety of substances including calcium oxalate, uric acid, and struvite (magnesium, ammonium and phosphate). According to the Marshall Pathogenesis, there are two factors that seem to play a role in kidney stone formation: elevated levels of 1,25-D and the presence of bacteria.  
  
 Patients on the Marshall Protocol (MP) are somewhat less likely to get kidney stones, especially in later stages of the treatment, due to the restoration of proper vitamin D metabolism. Those patients who do develop kidney stones since starting the MP, should know they are a result of months or years of development and not due to the effects of the MP. The MP should prevent recurrence. Patients on the Marshall Protocol (MP) are somewhat less likely to get kidney stones, especially in later stages of the treatment, due to the restoration of proper vitamin D metabolism. Those patients who do develop kidney stones since starting the MP, should know they are a result of months or years of development and not due to the effects of the MP. The MP should prevent recurrence.
Line 100: Line 100:
 <DiseaseHierarchy> <DiseaseHierarchy>
  
-EDIT+
  
   * legacy content   * legacy content
home/diseases/kidney_stones.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.